Ganglioside profiling by ion mobility and mass spectrometry imaging identifies distinct biomolecular isomers in Niemann-Pick Disease
Frederiksen, S. F.; Penanes, P. A.; Rasmussen, C. L. M.; Burkhart, A.; Heegaard, C. W.; Wustner, D.; Jensen, O. N.
Show abstract
Gangliosides are glycosphingolipids implicated in the neurodegenerative pathology of Niemann-Pick disease type C2 (NPC2 disease), where accumulation of GM2 and GM3 is a hallmark of disrupted lipid trafficking and disease progression. Some gangliosides are structural isomers with identical molecular composition and mass, making them difficult to distinguish by mass spectrometry imaging (MSI) alone and leaving their spatial distributions unresolved. To address this challenge, we combined ion mobility spectrometry with mass spectrometry imaging for isomer-resolved ganglioside analysis. We assessed ganglioside complexity in wild-type (Npc2+/+) and NPC2-deficient mice with or without AAV-BR1-mediated NPC2 gene therapy (Npc2-/- AAV-BR1-NPC2 and Npc2-/- vehicle) using matrix-assisted laser desorption ionization (MALDI) MSI, and imaging-parallel reaction monitoring-parallel accumulation serial fragmentation (iPRM-PASEF-MS/MS) for in situ brain tissue analysis. Trapped ion mobility spectrometry (TIMS) enabled gas-phase separation of isomeric gangliosides, while iPRM-PASEF-MS/MS facilitated structural discrimination based on diagnostic fragment ions and identification of molecular modifications. Brain sections were analyzed by MALDI-MSI at 20m spatial resolution, with selected regions examined using post-ionization imaging by MALDI-2 at 5m. 59 mobility-resolved ganglioside features representing 23 putative annotations were identified, including separation and spatial mapping of GM1a/GM1b and GD1a/GD1b isomers. Notably, unreported modifications of gangliosides were identified, including GM1 fucosylation in Npc2-/- mice and GD1 O-acetylation exclusively detected in Npc2+/+ mice. Spatial ganglioside profiling by MSI demonstrated that gene therapy of Npc2-/- mice partially restored normal ganglioside localization in brain, indicating modulation of lipid storage. This study establishes isomer-resolved lipid imaging for investigating ganglioside alterations in disease models and the effects of therapeutic intervention.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A Temporal Quantitative Profiling of Newly Synthesized Proteins during Aβ Accumulation 92%
- Direct mass spectrometry-based detection and antibody sequencing of Monoclonal Gammopathy of Undetermined Significance from patient serum - a case study. 92%
- LC-MS/MS-PRM Quantification of IgG glycoforms using stable isotope labeled IgG1 Fc glycopeptide standard 92%
Similar papers in this journal
- Rapid Screening of COVID-19 Disease Directly from Clinical Nasopharyngeal Swabs using the MasSpec Pen Technology 93%
- Omics Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue using a Multi-Class Internal Standard Mixture 92%
- Lipid signatures and inter-cellular heterogeneity of naive and lipopolysaccharide-stimulated human microglia-like cells 92%
Similar papers in this journal
- DBDA matrix increases ion abundance of fatty acids and sulfatides in MALDI-TOF and mass spectrometry imaging studies 94%
- Application of post glycosylation modifying enzymes for mass spectrometry imaging of modified N-glycans in situ. 92%
- Improving MALDI Mass Spectrometry Imaging Performance: Low-Temperature Thermal Evaporation for Controlled Matrix Deposition and Improved Image Quality 92%
Similar papers in this journal
- In-depth analysis of the tear fluid glycoproteome reveals diverse lacritin glycosylation and spliceoforms 91%
- Amyloid-β oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation 90%
- Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite 89%
Similar papers in this journal
- Mass spectrometric method for the unambiguous profiling of cellular dynamic glycosylation. 92%
- In vivo prenylomic profiling in the brain of a transgenic mouse model of Alzheimer's disease reveals increased prenylation of a key set of proteins 92%
- Dual-Probe Activity-Based Protein Profiling Reveals Site-Specific Differences in Protein Binding of EGFR-Directed Drugs 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.